• Maine Breast Cancer Coalition collaborates with other organizations to win the battle against breast cancer.

  • We advocate for important initiatives for research, treatment, and the end of breast cancer.

To find out more about current issues in breast cancer advocacy and legislation visit the
National Breast Cancer Coalition web site at

For the latest facts about breast cancer from the National Breast Cancer Coalition


MBCC Volunteers' Take Leadership Role in Ending Breast Cancer

From May 3-5, 2015, Maine Breast Cancer Coalition volunteers Bethany Zell (MBCC President) and Laurel Bezanson (MBCC Advocacy Committee Chair) once again headed to Washington, DC to represent MBCC at the 2015 National Breast Cancer Coalition Advocate Leadership Summit and to meet with Maine's legislators.

Breast Cancer Deadline 2020® is the National Breast Cancer Coalition's global initiative to know how to end breast cancer by January 1, 2020. According to Bethany, "As leaders in the breast cancer movement and supporters of Breast Cancer Deadline 2020®, we are committed to being a part of this important work."

Laurel wrote,
“In 1989 my life changed. At age 38, I was diagnosed with breast cancer and already had ten positive lymph nodes. My treatment was toxic, expensive and lengthy. After treatment, I needed to do something to change the status quo. Subsequently I became involved with the Maine Breast Cancer Coalition and the National Breast Cancer Coalition. I needed to make a difference in other peoples’ lives that were affected by this all-too-common disease. I have been an active member of both groups since 1993. Attending the yearly NBCC Summit is key to ending breast cancer!”

Find out more about how you can get involved.


Breast Cancer Deadline 2020: To Know How to End Breast Cancer by January 1, 2020

The National Breast Cancer Coalition (NBCC) has a unique history and an unmatched record of accomplishment in breast cancer. Since NBCC’s inception in 1991, the organization’s mission has been to end breast cancer. Now, NBCC has set a deadline: Breast Cancer Deadline 2020® – to know how to end breast cancer by January 1, 2020.

According to NBCC, “These are not just words; we have a strategic plan to get there.  While the vast majority of resources are focused on finding the next treatment, NBCC is doing something very different. We are bringing together unprecedented collaborations among scientists, visionaries, and advocates to catalyze, plan and implement work in two major areas: how to prevent metastasis to save lives and how to prevent the development of breast cancer.”

Beginning with a baseline report in May 2011, NBCC has issued Annual Progress Reports about Breast Cancer Deadline 2020®. These reports summarize the state of breast cancer as well as the status of NBCC’s work to end breast cancer, hold us and the entire breast cancer community accountable to the Deadline.  Starting in 2013, NBCC  convened biennial Leadership Summits to examine progress and provide guidance and direction for the ongoing work to achieve Breast Cancer Deadline 2020®.

To find out more about Breast Cancer Deadline 2020 and the National Breast Cancer Coalition go to


Maine Breast Cancer Coalition Representatives Attend 2013 Breast Cancer Deadline 2020® Advocate Summit
By Bethany Zell

            “It’s not just about pink ribbons
             or awareness . . . people ARE aware of
             breast cancer’s path of destruction.” 

As Laurel Bezanson of Portland and Bethany Zell of Caribou arrived in Washington, DC on May 3, 3013, they knew that this message would be at the core of the next four days and were excited to dig in. From new statistics on breast cancer research to a comprehensive overview of the status quo of breast cancer incidence and treatment; from discussions on how we can change the conversation to END breast cancer to the impact of over-diagnosis and over-treatment of breast cancer; from learning how to mobilize our grassroots efforts at a local level to the politics that are vital to the end of this disease, the 2013 Inaugural Advocate Leadership Summit of the National Breast Cancer Coalition did not disappoint. 

Approximately 150 breast cancer advocates from all over the world came to glean leadership skills and strategies, as well as ideas and advanced learning on breast cancer. With an intentionally smaller attendance than in previous years, the advocates from Maine were afforded more intimate small-group interactions with leaders in the breast cancer community, like Dr. Susan Love, the president of the Dr. Susan Love Research Foundation and author of “Dr. Susan Love's Breast Book” and Dr. Dennis Slamon, chief of Hematology and Oncology at UCLA whose research led to the development of the breast cancer drug, Herceptin. 

On Tuesday, May 7, as the summit culminated, Laurel and Bethany had the honor of sharing their experience and knowledge on breast cancer with each of Maine’s Senators and Congressmen in a whirlwind day on Capitol Hill. As a result of those visits, Senator Susan Collins has again agreed to be a lead sponsor of the Senate’s Accelerating the End of Breast Cancer Act, and Rep. Chellie Pingree has signed on to the House version. Find out more at

photo: Maine Breast Cancer Coalition representatives, Bethany Zell (left) and Laurel Bezanson (right), with Senator Susan Collins


Representatives from Maine Breast Cancer Coalition Attended 2012 Advocate Summit

Press Release by Bethany Zell, Maine Breast Cancer Coalition volunteer
Washington, DC – May 8, 2012

Representing the Maine Breast Cancer Coalition, Laurel Bezanson of South Portland and Bethany Zell of Caribou attended the National Breast Cancer Coalition (NBCC) Advocate Summit in Washington, DC from May 5-8. The summit is the NBCC’s national meeting of breast cancer advocates from around the world. There were sessions on the latest scientific research, training in effective advocacy strategies, and presentations by respected researchers in the field, grassroots leaders from around the country, and prominent public policy experts.

The summit also involved advocates in the work to achieve Breast Cancer Deadline 2020 - NBCC's strategic plan to end breast cancer by January 1, 2020. The highlight of the summit was a day on Capitol Hill lobbying for the “Accelerating the End of Breast Cancer Act” (HR 3067) and the Department of Defense Breast Cancer Research Program. 

Laurel Bezanson and a fellow attendee from Maine, Bethany Zell of Caribou, met with the staff of Congressman Mike Michaud and Congresswoman Chellie Pingree, who had both already signed on to HR 3067. The evening culminated with a Congressional Reception in the Kennedy Caucus Room of the Russell Senate Building. 

At the reception, Maine Senator Susan Collins was awarded with the NBCC’s Breast Cancer Deadline 2020 Award for her advocacy on behalf of people diagnosed with breast cancer, and especially for her continuing fight to maintain the Department of Defense’s Breast Cancer Research Program.  While accepting this award, Senator Collins made the exciting announcement that she will support the bill for “Accelerating the End of Breast Cancer” once it is introduced in the Senate.

As a breast cancer survivor and active member of the Maine Breast Cancer Coalition, Laurel has made it her mission to inform and advocate for the end of breast cancer and the National Breast Cancer Coalition’s Breast Cancer Deadline 2020.

Currently, the NBCC is gathering signatures on a petition to the President of the United States.  “We want to gather 290,000 signatures in total, one for each person who will be diagnosed with breast cancer this year.  Regionally, we want to collect 1,485 signatures from the state of Maine because that is how many people will be diagnosed in Maine this year,” said Laurel Bezanson.

Shown in photo L to R: Laurel Bezanson, Senator Collins, Bethany Zell


207-945-0008 or 1-800-928-2644

Copyright © 2015 Maine Breast Cancer Coalition | Site powered by ContentCafé